Sydney-based Pharmaxis(ASX:PXS) has announced it is progressing the development of an oral anti‐fibrotic Lysyl Oxidase (LOX) inhibitor for the treatment of myelofibrosis and pancreatic cancer. …
Latest Video
New Stories
-
The COVID-19 vaccine manufacturing and supply deals
August 7, 2020 - - Latest News -
Greg Hunt moves to extend industry agreements
August 7, 2020 - - Latest News -
CSL says it is now 'exploring ways' to manufacture another vaccine
August 7, 2020 - - Latest News -
Goldman Sachs: US will be first because it has invested the most
August 6, 2020 - - Latest News -
What is the strategy? Is there a strategy?
August 6, 2020 - - Comment -
Neurohack brainstorms solutions for young people with SMA
August 6, 2020 - - Latest News -
Ventolin with dose counter makes it to the PBS
August 6, 2020 - - Latest News